The biotech & biopharma sectors started to get off the schneid on Monday -- after a deep slump over the previous three weeks within an even larger and more-brutal eight-month bear marketThe sector got off life support in part as a result of standout earnings from one of my previous "Best Ideas," Eagle Pharmaceuticals (EGRX), which posted one of th...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.